Photofrin vs Visudyne: Side-by-Side Comparison
Quick answer: Photofrin and Visudyne are both photosensitizing agent (photodynamic therapy) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Photofrin | Visudyne |
|---|---|---|
| Drug class | Photosensitizing agent (photodynamic therapy) | Photosensitizing agent (photodynamic therapy) |
| ATC code | L01XD01 | S01LA01 |
| Primary indications | Esophageal cancer, Endobronchial non-small cell lung cancer | Wet age-related macular degeneration, Pathologic myopia |
| Mechanism | Porfimer sodium accumulates in tumor cells and generates cytotoxic singlet oxygen upon laser light activation | Verteporfin is activated by non-thermal red light to generate reactive oxygen species causing local damage to neovascular endothelium |
| Common dose | 2 mg/kg IV, followed by laser illumination 40-50 hours later | 6 mg/m² IV infusion followed by laser activation |
| Detail page | Photofrin details → | Visudyne details → |
How to choose between Photofrin and Visudyne
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Photosensitizing agent (photodynamic therapy) on iMedic · Photofrin full details · Visudyne full details
Frequently asked questions
Is Photofrin better than Visudyne?
Neither is universally 'better.' They are both photosensitizing agent (photodynamic therapy) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Photofrin to Visudyne?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Photofrin and Visudyne have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Photofrin and Visudyne available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.